Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Parcel Service
UPS
|
+$428M |
| 2 |
DexCom
DXCM
|
+$384M |
| 3 |
WIX.com
WIX
|
+$359M |
| 4 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$254M |
| 5 |
Caesars Entertainment
CZR
|
+$246M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.14B |
| 2 |
Microchip Technology
MCHP
|
+$535M |
| 3 |
Merck
MRK
|
+$512M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$444M |
| 5 |
Illumina
ILMN
|
+$413M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.59% |
| 2 | Healthcare | 18.35% |
| 3 | Consumer Discretionary | 11.3% |
| 4 | Financials | 10.45% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Cadence Design Systems
CDNS
$90B
| $567M | 0.24% |
4,142,194
+630,767
| +18% | +$83.6M |
|
102
CarMax
KMX
$8.27B
| $563M | 0.24% |
4,359,859
+209,627
| +5% | +$25.9M |
|
103
Amdocs
DOX
$5.53B
| $559M | 0.24% |
7,226,886
+315,041
| +5% | +$24.3M |
|
104
Dollar General
DG
$25.9B
| $548M | 0.23% |
2,531,395
+199,590
| +9% | +$41.9M |
|
|
HZNP
105
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $545M | 0.23% |
5,824,194
-1,772,963
| -23% | -$163M |
|
106
Hasbro
HAS
$12.6B
| $544M | 0.23% |
5,753,756
-188,209
| -3% | -$18.1M |
|
107
Zurn Elkay Water Solutions
ZWS
$8.07B
| $539M | 0.23% |
22,374,854
-385,903
| -2% | -$9.28M |
|
108
Sarepta Therapeutics
SRPT
$1.66B
| $536M | 0.23% |
6,894,765
+722,902
| +12% | +$54.8M |
|
109
Marvell Technology
MRVL
$174B
| $524M | 0.22% |
8,979,586
+2,748,073
| +44% | +$134M |
|
110
Ingersoll Rand
IR
$33B
| $520M | 0.22% |
10,656,388
+1,082,161
| +11% | +$53.1M |
|
111
Cisco
CSCO
$450B
| $520M | 0.22% |
9,812,507
-1,849,962
| -16% | -$97.3M |
|
112
Target
TGT
$62.1B
| $512M | 0.22% |
2,117,825
-431,136
| -17% | -$94.4M |
|
113
Global Payments
GPN
$22.1B
| $509M | 0.22% |
2,715,251
-67,609
| -2% | -$13.6M |
|
114
W.R. Berkley
WRB
$28B
| $508M | 0.22% |
15,360,089
+462,042
| +3% | +$16M |
|
|
AVLR
115
DELISTED
Avalara, Inc.
AVLR
| $506M | 0.22% |
3,126,379
+77,709
| +3% | +$10.8M |
|
116
Ziff Davis
ZD
$1.9B
| $487M | 0.21% |
4,068,536
+495,394
| +14% | +$54.4M |
|
117
ICU Medical
ICUI
$3.93B
| $481M | 0.21% |
2,335,116
-90,766
| -4% | -$18.7M |
|
118
Globus Medical
GMED
$10.4B
| $477M | 0.2% |
6,157,383
-265,423
| -4% | -$18.9M |
|
119
Alliant Energy
LNT
$19.4B
| $473M | 0.2% |
8,483,635
-121,764
| -1% | -$6.9M |
|
120
Constellation Brands
STZ
$22.2B
| $469M | 0.2% |
2,007,242
+409,506
| +26% | +$96.1M |
|
121
Starbucks
SBUX
$118B
| $461M | 0.2% |
4,125,638
-548,677
| -12% | -$62M |
|
122
IBM
IBM
$202B
| $456M | 0.2% |
3,255,357
+113,047
| +4% | +$15.5M |
|
|
ATVI
123
DELISTED
Activision Blizzard
ATVI
| $456M | 0.2% |
4,775,837
-419,819
| -8% | -$39.8M |
|
124
Dynatrace
DT
$12.1B
| $452M | 0.19% |
7,740,001
+741
| +0% | +$38.7K |
|
|
SEE
125
DELISTED
Sealed Air
SEE
| $440M | 0.19% |
7,420,005
-3,940,357
| -35% | -$212M |
|
Similar funds
Janus Henderson Group's Q2 2021 Portfolio in Review
As of Q2 2021, Janus Henderson Group held 1,725 positions worth $234B, up 6.7% from $219B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Janus Henderson Group's Q2 2021 filing shows 172 new, 741 increased, 667 reduced and 123 closed positions. Its largest new stake was Centessa Pharmaceuticals: 5,680,933 shares worth $120M. The largest sale was Apple, an estimated $1.14B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2021 buy was Centessa Pharmaceuticals: 5,680,933 shares worth $120M.
- Janus Henderson Group added most to United Parcel Service in Q2 2021, an estimated $428M increase.
- Janus Henderson Group's biggest Q2 2021 reduction was Apple, cutting an estimated $1.14B.
- Janus Henderson Group fully exited PRA Health Sciences, Inc. in Q2 2021, selling an estimated $368M.
- Janus Henderson Group's ten largest holdings make up 23% of its $234B portfolio in Q2 2021.
- Janus Henderson Group opened 172 new positions and closed 123 in Q2 2021.
- Janus Henderson Group's portfolio value rose 6.7% quarter-over-quarter to $234B.
Based on Janus Henderson Group's 13F filing for Q2 2021, filed 16 Aug 2021.